Antibody responses to Escherichia coli O157 and other lipopolysaccharides in healthy children and adults

Clinical and Diagnostic Laboratory Immunology

Volumn 10, Issue 5, 2003, Pages 797-801

  Navarro, Armando ^a   Eslava, Carlos ^a   Hernandez, Ulises ^a   Navarro Henze, Jose Luis ^b   Aviles, Magali ^b   Garcia de la Torre, Guadalupe ^a   Cravioto, Alejandro ^a,c  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b Laboratorio Estatal de Salud Publica   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; ESCHERICHIA COLI LIPOPOLYSACCHARIDE;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BREAST MILK; CLINICAL FEATURE; CONTROLLED STUDY; CROSS REACTION; DIARRHEA; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI O116; ESCHERICHIA COLI O157; ESCHERICHIA COLI O7; FEMALE; GROUPS BY AGE; HUMAN; HUMAN EXPERIMENT; INFANT; MEXICO; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RABBIT; REFERENCE VALUE; SERODIAGNOSIS; SEROTYPE; SERUM; SERUM BACTERICIDAL ACTIVITY; WESTERN BLOTTING;

ADULT; ANIMALS; ANTIBODIES, BACTERIAL; BLOOD BACTERICIDAL ACTIVITY; BLOTTING, WESTERN; CHILD, PRESCHOOL; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; HUMANS; LIPOPOLYSACCHARIDES;

EID: 0141787167     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.10.5.797-801.2003     Document Type: Article

References (38)

1. Banatvala N., P. M. Griffin, K. D. Greene, T. J. Barrett, W. F. Bibb, J. H. Green, J. G. Wells, and the Hemolytic Uremic Syndrome Study Collaborators. 2001. The United States national prospective hemolytic uremic syndrome study: microbiologic, serologic, clinical, and epidemiologic findings. J. Infect. Dis. 183:1063-1070.
2. Barrett, T. J., H. Lior, J. H. Green, R. Khakhria, J. G. Wells, B. P. Bell, K. D. Greene, J. Lewis, and P. M. Griffin. 1994. Laboratory investigation of a multistate food-borne outbreak of Escherichia coli O157:H7 by using pulsed-field gel electrophoresis and phage typing. J. Clin. Microbiol. 32:3013-3017.
3. Belongia E. A., P.-H. Chyou, R. T. Greenlee, G. Perez-Perez, W. F. Bibb, and E. O. DeVries. 2003. Diarrhea incidence and farm-related risk factor for Escherichia coli O157:H7 and Campylobacter jejuni antibodies among rural children. J. Infect. Dis. 187:1460-1468.
4. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
5. Chart, H., O. A. Okubadejo, and B. Rowe. 1992. The serological relationship between Escherichia coli O157 and Yersinia enterocolitica O9 using sera from patients with brucellosis. Epidemiol. Infect. 108:77-85.
6. Chart, H., and B. Rowe. 1992. Improved detection of infection by Escherichia coli O157 in patients with haemolytic uraemic syndrome by means of IgA antibodies to lipopolysaccharide. J. Infect. 24:257-261.
7. Chart, H., and B. Rowe. 1993. Antibody cross-reactions with lipopolysaccharide from E. coli 0157 after cholera vaccination. Lancet 341:1282.
8. Chart, H., H. R. Smith, S. M. Scotland, B. Rowe, D. V. Milford, and C. M. Taylor. 1991. Serological identification of Escherichia coli O157:H7 infection in haemolytic uraemic syndrome. Lancet 337:138-140.
9. Chart, H., G. A. Willshaw, T. Cheasty, and B. Rowe. 1993. Structure and antigenic properties of Citrobacter freundii lipopolysaccharides. J. Appl. Bacteriol. 74:583-587.
10. Conlan, J. W., and M. B. Perry. 1998. Susceptibility of three strains of conventional adult mice to intestinal colonization by an isolate of Escherichia coli O157:H7. Can. J. Microbiol. 44:800-805.
11. Conlan, J. W., R. KouLee, A. Webb, and M. B. Perry. 1999. Salmonella landau as a live vaccine against Escherichia coli O157:H7 investigated in a mouse model of intestinal colonization. Can. J. Microbiol. 45:723-731.
12. Cordovéz, A., V. Prado, L. Maggi, J. Cordero, J. Martinez, A. Misraji, R. Rios, G. Soza, A. Ojeda, and M. M. Levine. 1992. Enterohemorrhagic Escherichia coli associated with hemolytic-uremic syndrome in Chilean children. J. Clin. Microbiol. 30:2153-2157.
13. Cravioto, A., R. E. Reyes, F. Trujillo, F. Uribe, A. Navarro, J. M. De La Roca, J. M. Hernandez, G. Perez, and V. Vazquez. 1990. Risk of diarrhea during the first year of life associated with initial and subsequent colonization by specific enteropathogens. Am. J. Epidemiol. 131:886-904.
14. Cravioto, A., A. Tello, H. Villafán, J. Ruiz, S. del Vedovo, and J. R. Neeser. 1991. Inhibition of localized adhesion of enteropathogenic Escherichia coli to HEp-2 cells by immunoglobulin and oligosaccharide fractions of human colostrum and breast milk. J. Infect. Dis. 163:1247-1255.
15. Ewing W. H. 1986. Edwards and Ewing's identification of Enterobacteriaceae. Elsevier Science Publishing Inc., New York, N.Y.
16. Greatorex, J. S., and G. M. Thorne. 1994. Humoral immune response to Shiga-like toxin and Escherichia coli O157 lipopolysaccharide in hemolyticuremic syndrome patients and healthy subjects. J. Clin. Microbiol. 32:1172-1178.
17. Guth, B. E. C., R. Lopes de Souza, T. M. I. Vaz, and K. Irino. 2002. First Shiga toxin-producing Escherichia coli isolate from a patient with hemolytic uremic syndrome, Brazil. Emerg. Infect. Dis. 8:535.
18. Laemmli, U. K. 1970. Cleavage of structural protein during the assembly of the head of bacteriophage T4. Nature 227:680-685.
19. Lopez, E. L., M. Diaz, S. Grinstein, S. Devoto, F. Mendilaharzu, B. E. Murray, S. Ashkenazi, E. Rubeglio, M. Woloj, M. Vasquez, M. Turco, L. K. Pickering, and T. G. Cleary. 1989. Hemolytic uremic syndrome and diarrhea in Argentine children: the role of Shiga-like toxins. J. Infect. Dis. 160:469-475.
20. Mattar, S., and E. Vásquez. 1998. Escherichia coli O157:H7 infection in Colombia. Emerg. Infect. Dis. 4:126-127.
21. Nataro, J. P., and J. B. Kaper. 1998. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11:142-201.
22. Nishiuchi, Y., M. Doe, H. Hotta, and K. Kobayashi. 2000. Structure and serologic properties of O-specific polysaccharide from Citrobacter freundii possessing cross-reactivity with Escherichia coli O157:H7. FEMS Immunol. Med. Microbiol. 28:163-171.
23. Notenboom R. H., A. Borczyk, M. A. Karmali, and L. M. C. Duncan. 1987. Clinical relevance of a serological cross-reaction between Escherichia coli O157 and Brucella abortus. Lancet ii:745.
24. Park, C. H., E. A. Martin, and E. L. White. 1998. Isolation of a nonpathogenic strain of Citrobacter sedlakii which expresses Escherichia coli O157 antigen. J. Clin. Microbiol. 36:1408-1409.
25. Perry, M. B., D. R. Bundle, M. A. J. Gidney, and H. Lior. 1988. Identification of Escherichia coli serotype O157 strains by using a monoclonal antibody. J. Clin. Microbiol. 26:2391-2394.
26. Perry, M. B., L. MacLean, and D. W. Griffith. 1986. Structure of O-chain polysaccharide of the phenol-phase soluble lipopolysaccharide of Escherichia coli O157:H7. Biochem. Cell. Biol. 64:21-28.
27. Qadri, F., G. Mohi, J. Hossain, T. Azim, A. M. Khan, M. A. Salam, R. B. Sack, M. J. Albert, and A. M. Svennerholm. 1995. Comparison of the vibriocidal antibody response in cholera due to Vibrio cholerae O139 Bengal with the response in cholera due to Vibrio cholerae O1. Clin. Diagn. Lab. Immunol. 2:685-688.
28. Reymond, D., R. P. Johnson, M. A. Karmali, M. Petric, M. Winkler, S. Johnson, K. Rahn, S. Renwick, J. Wilson, R. C. Clarke, and J. Spika. 1996. Neutralizing antibodies to Escherichia coli Vero cytotoxin 1 and antibodies to O157 lipopolysaccharide in healthy farm family members and urban residents. J. Clin. Microbiol. 34:2053-2057.
29. Rice, E. W., E. G. Sowers, C. H. Johnson, M. E. Dunnigan, N. A. Strockbine, and S. C. Edberg. 1992. Serological cross-reactions between Escherichia coli O157 and other species of the genus Escherichia. J. Clin. Microbiol. 30:1315-1316.
30. Siddons, C. A., and P. A. Chapman. 1993. Detection of serum and faecal antibodies in haemorrhagic colitis caused by Escherichia coli O157. J. Med. Microbiol. 39:408-415.
31. Stuart, F. A., and M. J. Corbel. 1982. Identification of a serological cross-reaction between Brucella abortus and Escherichia coli O157. Vet. Rec. 110:202-203.
32. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76:4350-4354.
33. Vinogradov, E., J. W. Conlan, and M. B. Perry. 1998. Serological cross-reaction between the lipopolysaccharide O-polysaccharide antigens of Escherichia coli O157:H7 and strains of Citrobacter freundii and Citrobacter sedlakii. FEMS Microbiol. Lett. 190:157-161.
34. Viret, J. F., D. Favre, B. Wegmüller, C. Herzog, J. U. Que, S. J. Cryz, Jr., and A. B. Lang. 1999. Mucosal and systemic immune response in humans after primary and booster immunizations with orally administered invasive and noninvasive live attenuated bacteria. Infect. Immun. 67:3680-3685.
35. Watanabe, H., A. Wada, Y. Inagaki, K. Itoh, and K. Tamura. 1996. Outbreaks of enterohaemorrhagic Escherichia coli O157:H7 infection by two different genotype strains in Japan, 1996. Lancet 348:831-832
36. Westphal, O., and and K. Jann. 1965. Bacterial lipopolysaccharide: extraction with phenol-water and further applications of the procedure. Methods Carbohydr. Chem. 5:83-91.
37. Willshaw, G. A., T. Cheasty, H. R. Smith, S. J. O'Brien, and G. K. Adak. 2001. Verocytotoxin-producing Escherichia coli (VTEC) O157 and other VTEC from human infections in England and Wales: 1995-1998. J. Med. Microbiol. 50:135-142.
38. Wilson, J. B., R. C. Clarke, S. A. Renwick, K. Rahn, R. P. Johnson, M. A. Karmali, H. Lior, D. Alves, C. L. Gyles, K. S. Sandhu, S. A. McEwen, and J. S. Spika. 1996. Vero cytotoxigenic Escherichia coli infection in dairy farm families. J. Infect. Dis. 174:1021-1027.